Target intelligence / Profile preview

Phosphorylase kinase catalytic subunit gamma-2 (PHKG2)

Target
PHKG2
Molecular classification
Enzyme, Serine/threonine-protein kinase, Phosphorylase kinase complex component
01

Overview

Phosphorylase kinase catalytic subunit gamma-2 (PHKG2) is the catalytic gamma subunit of phosphorylase kinase, a hexadecameric enzyme complex essential for initiating glycogen breakdown by phosphorylating glycogen phosphorylase. PHKG2 encodes the liver- and testis-specific isoform of this enzyme, mediating the regulatory effect of neural and hormonal signals on glucose mobilization. The gamma subunit contains the enzymatic activity, while regulatory alpha, beta, and delta (calmodulin) subunits control it through phosphorylation and calcium sensitivity. PHKG2 deficiency leads to glycogen storage disease type IXc (autosomal liver glycogenosis), characterized by enlarged liver, hypoglycemia, and potential progression to fibrosis or cirrhosis. Recent research suggests PHKG2 may influence cell death pathways (such as ferroptosis) in liver and gastric cancer models, but no targeted drugs exist for this protein

Other names
Phosphorylase kinase, gamma 2 (testis/liver)Phosphorylase b kinase gamma catalytic chain, liver/testis isoformPHK-gamma-LTPHK-gamma-TPSK-C3GSD9CPhosphorylase kinase subunit gamma-2Serine/threonine-protein kinase PHKG2
02

Mechanism of action

Not established for any approved drug. Theoretical: Enzyme activation/inhibition through modulation of PHKG2’s kinase activity, targeting the glycogenolysis pathway

03

Biological functions

Regulation of glycogen breakdown (glycogenolysis)Phosphorylation of glycogen phosphorylaseNeural and hormonal response mediation in glucose metabolismRegulation of cell death pathways (ferroptosis, context-dependent)
04

Disease associations

Glycogen storage disease type IXc (GSD9C)Liver glycogenosisPotential roles in gastric cancer and tumor cell ferroptosis (investigational/experimental)
05

Safety considerations

Therapeutic modulation may disrupt glucose homeostasis, risking hypoglycemia or glycogen accumulationPotential off-target effects due to roles in metabolic pathways central to energy balanceRisk of hepatomegaly, liver dysfunction if enzyme function is excessive or suppressed
06

Interacting drugs

None specifically approved or clinically established for PHKG2; research drugs modifying glycogen metabolism may interact with the pathway (e.g., enzyme replacement therapies in broader glycogen storage diseases), but no direct approved inhibitors or activators for PHKG2
07

Biomarkers

Mutation or deficiency in PHKG2 gene/protein (for diagnosis of GSD IXc)Liver phosphorylase kinase activity (functional enzymatic assay)Glycogen content in liver biopsy (for phenotypic diagnosis)

Beyond the preview

Go deeper on Phosphorylase kinase catalytic subunit gamma-2 (PHKG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphorylase kinase catalytic subunit gamma-2 (PHKG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call